SEARCH

SEARCH BY CITATION

References

  • 1
    Jahnsen J, Falch J, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn’s disease but not in patients with ulcerative colitis: a population based study. Gut 1997; 40: 313 19.
  • 2
    Ghosh S, Cowen S, Hannan W, Ferguson A. Low bone mineral density in Crohn’s disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994; 107: 1031 9.
  • 3
    Compston J. Review article: osteoporosis, corticosteroids and inflammatory bowel disease. Aliment Pharmacol Ther 1995; 9(3): 237 50.
  • 4
    Hessov I, Mosekilde L, Melsen F. Osteopenia with normal␣vitamin D metabolites after small bowel resection for Crohn’s disease. Scand J Gastroenterol 1984; 19: 691 6.
  • 5
    Croucher P, Vedi S, Motley R, Garrahan N, Stanton M, Compston J. Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteoporosis Int 1993; 3(5): 236 41.
  • 6
    Blumsohn A & Eastell R. The performance and utility of biochemical markers of bone turnover: do we know enough to use them in clinical practice? Ann Clin Chem 1997; 34(5): 449 59.
  • 7
    Kjeldsen J, Junker P, Schaffalitzky de Muckadell O. Evidence that collagen 1 turnover is increased in active Crohn’s disease. Gastroenterology 1994; 104(Suppl. 4): A712(Abstract).
  • 8
    Abitbol V, Roux C, Chaussade S, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 417 22.
  • 9
    Silvennoinen J, Ristelli L, Karttunen T, Risteli J. Increased degradation of type 1 collagen in patients with inflammatory bowel disease. Gut 1996; 38: 223 8.
  • 10
    Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997; 40: 228 33.
  • 11
    Hyams J, Wyzga N, Kreutzer D, Justinich C, Gronowicz G. Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study. J Pediatr Gastroenterol Nutr 1997; 24(3): 289 95.
  • 12
    Harvey R & Bradshaw J. A simple index of Crohn’s disease activity. Lancet 1980; March 8th: 514.
  • 13
    Bernstein C, Seeger L, Sayre J, Anton P, Artinian L, Shanahan F. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Min Res 1995; 10(2): 250 5.
  • 14
    Lukert B & Raisz L. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990; 112(5): 352 64.
  • 15
    Godschalk M & Downs R. Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Min Res 1988; 3: 113 15.
  • 16
    Lin C, Moniz C, Chambers T, Chow J. Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology 1996; 111: 1263 71.
  • 17
    Uebelhart D, Schlemmer A, Johansen J, Gineyts E, Christiansen C, Delmas P. Effect of menopause and hormone replacement on the urinary excretion of pyridinum crosslinks. J Clin Endocrinol Metab 1991; 72: 367 73.
  • 18
    Van Daele PLA, Siebel MJ, Burger H , et al. Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study. Br Med J 1997; 312: 482 3.
  • 19
    Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A. Prevention of bone mineral loss in patients with Crohn’s disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol 1995; 7(7): 609 14.
  • 20
    Clements D, Compston J, Evans W, Rhodes J. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut 1993; 34: 1543 6.
  • 21
    Robinson R, Krwyzicki T, Almond L, et al. The effect of low impact exercise on bone mineral density in patients with Crohn’s disease. A randomised controlled study. Gut 1997; 41(Suppl. 3): A17(Abstract).
  • 22
    Adami S & Zamberlan N. Adverse effects of bisphosphonates. Drug Safety 1996; 14: 158 70.